Chicagoland Diabetes TrialNet Clinical Center

描述（由申请人提供）：本申请“芝加哥TrialNet临床中心”是对RFA -DK-13-010 1型糖尿病TrialNet临床中心（U 01）的回应。在这里，我们描述了一个共同的努力，从芝加哥和倡导儿童医院（ACH）网站（公园岭和橡树草坪，伊利诺伊州）和倡导卫生保健（AHC）在芝加哥地区创建一个新的临床中心。2012年，这些组织沿着我们的其他附属机构（Lurie儿童医院）和合作机构共接诊了9000多名1型糖尿病（T1 D）患者。总之，这些实践地点沿着其他参与的关键成人和儿科糖尿病从业人员从芝加哥达到超过1200万人在两个小时的车程内的筛选位置。芝加哥社区是青少年糖尿病研究基金会（JDRF）和美国糖尿病协会（ADA）的坚定支持者，在1型糖尿病（T1 D）的临床试验中代表性不足。该合作伙伴关系将汇集致力于T1 D研究和临床护理的主要医疗中心的资源，以覆盖芝加哥地区约10万T1 D患者（约占该地区人口的0.8%）及其家庭，以及每年预计的2000例T1 D新病例及其家庭。这一外联活动将涉及不同的社区，从美国最富有的一些社区到最缺乏服务的一些社区。我们将在成功创建美国最大的单基因糖尿病数据库的基础上再接再厉。我们将通过创新的社交媒体和直接沟通，结合媒体支持，直接访问当地的做法，由我们的机构和合作伙伴支持的社区活动，以及与大型信仰社区网络的联系，来参与更大的芝加哥社区。芝加哥大学100多年来一直致力于糖尿病研究，与Advocate儿童医院和其他合作伙伴一起，我们将为芝加哥地区的TrialNet招募和筛查带来新的活力，组织和目的。

DESCRIPTION (provided by applicant): This application "Chicagoland TrialNet Clinical Center" is in response to the RFA -DK-13-010 Type 1 Diabetes TrialNet Clinical Centers (U01). Here we describe a joint effort from the University of Chicago and Advocate Children's Hospital (ACH) sites (Park Ridge and Oak Lawn, Illinois) and Advocate Health Care (AHC) to create a new Clinical Center in the Chicagoland area. These organizations along with our other affiliate (Lurie Children's Hospital) and partner sites saw over 9000 patients with type 1 diabetes (T1D) in 2012. Together, these practice sites along with other participating key adult and pediatric diabetes practitioners from Chicago reach over 12 million individuals within a two-hour drive of a screening location. The Chicago community, strong supporters of the Juvenile Diabetes Research Foundation (JDRF) and American Diabetes Association (ADA), has been under-represented in clinical trials for Type 1 Diabetes (T1D). This partnership will bring together the resources of major medical centers committed to T1D research and clinical care to reach more of the estimated 100,000 individuals with T1D in the Chicagoland area (about 0.8% of the area population) and their families, as well as the 2000 projected new cases of T1D and their families each year. This outreach will involve diverse communities from some of the wealthiest to some of the most underserved in the United States. We will build on our success in creating the largest database for monogenic diabetes in the United States. We will engage the greater Chicagoland community through innovative social media and direct communications combining media support, direct visits to local practices, community events supported by our institutions and partners and outreach to large networks of faith communities. The University of Chicago has been committed to diabetes research for over 100 years, and together with Advocate Children's Hospital and other partners we will bring a new sense of energy, organization, and purpose to TrialNet recruitment and screening in the Chicagoland region.